Riemann, B; Krämer, J A; Schmid, K W; Dralle, H; Dietlein, M; Schicha, H; Sauerland, C; Frankewitsch, T; Schober, O; study group, M S D S (2010). Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trial. Nuklearmedizin, 49(3):79-84.
Full text not available from this repository.
View at publisher
The MSDS patients with locally aggressive differentiated thyroid cancer showed an excellent overall survival during a median follow-up of 6.1 years. According to the current AJCC/UICC 2009 classification, pT3 patients with minimal extrathyroidal extension revealed a significantly better event-free survival than pT4a patients with extensive extrathyroidal growth.
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Clinic for Nuclear Medicine|
|DDC:||610 Medicine & health|
|Deposited On:||31 Jan 2011 15:43|
|Last Modified:||28 Nov 2013 01:34|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page